Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are life-threatening complications following infection with one of the four serotypes of dengue virus (DENV). At present, no vaccine or antiviral therapies are available against dengue. Here, we characterized a panel of eight human or mous...
Main Authors: | Williams, Katherine L., Sukupolvi-Petty, Soila, Beltramello, Martina, Johnson, Syd, Sallusto, Federica, Lanzavecchia, Antonio, Diamond, Michael S., Harris, Eva |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573116/ |
Similar Items
-
Correction: Therapeutic Efficacy of Antibodies Lacking Fc. Receptor Binding against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
by: Williams, Katherine L., et al.
Published: (2013) -
In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
by: de Alwis, Ruklanthi, et al.
Published: (2011) -
Development of an in Vitro Potency Assay for Anti-anthrax Lethal Toxin Neutralizing Antibodies
by: Whiting, Gail, et al.
Published: (2012) -
Rational Engineering of a Human Anti-Dengue Antibody through Experimentally Validated Computational Docking
by: Simonelli, Luca, et al.
Published: (2013) -
Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
by: de Alwis, Ruklanthi, et al.
Published: (2011)